Subscribe

224 - Celgene

Courtesy of Celgene

The biopharmaceutical company is the maker of Thalomid and various other drugs that treat multimple myeloma, inflammatory diseases, and various forms of cancer.

Key Metrics & Financials (Last Fiscal Year)

Previous Rank254
Revenues ($M)$13003
Revenue Percent Change15.8%
Profits ($M)$2940.0
Profits Percent Change47.1%
Assets ($M)$30141
Market Value — as of March 29, 2018 ($M)$67102
Employees7467

More from FORTUNE

Company Facts

Employees7467
SectorHealth Care
IndustryPharmaceuticals
HQ LocationSummit, N.J.
CEOMark J. Alles
CEO Title-
Websitewww.celgene.com
Years on Fortune 500 List7

See Full List

Outbrain

More from FORTUNE